Page last updated: 2024-08-21

thiazoles and Encapsulating Peritoneal Sclerosis

thiazoles has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, D; Li, L; Su, X; Wang, Y; Yang, X; Yu, R; Zhou, G	1

Other Studies

1 other study(ies) available for thiazoles and Encapsulating Peritoneal Sclerosis

Article	Year
The PPARβ/δ agonist GW501516 attenuates peritonitis in peritoneal fibrosis via inhibition of TAK1-NFκB pathway in rats. Inflammation, 2014, Volume: 37, Issue:3 Topics: Animals; Cells, Cultured; Chemokine CCL2; Dietary Supplements; Disease Models, Animal; Glucose; I-kappa B Kinase; Inflammation; Interleukin-6; Lipopolysaccharides; Male; MAP Kinase Kinase Kinases; Peritoneal Dialysis; Peritoneal Fibrosis; Peritonitis; PPAR delta; PPAR-beta; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiazoles; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Uremia	2014

Article

Year

The PPARβ/δ agonist GW501516 attenuates peritonitis in peritoneal fibrosis via inhibition of TAK1-NFκB pathway in rats.

Inflammation, 2014, Volume: 37, Issue:3

Topics: Animals; Cells, Cultured; Chemokine CCL2; Dietary Supplements; Disease Models, Animal; Glucose; I-kappa B Kinase; Inflammation; Interleukin-6; Lipopolysaccharides; Male; MAP Kinase Kinase Kinases; Peritoneal Dialysis; Peritoneal Fibrosis; Peritonitis; PPAR delta; PPAR-beta; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiazoles; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Uremia

2014